Seeking Alpha

  Mast Therapeutics, Inc. (MSTX) - NYSEMKT

  • King Callahan | Send Message 17 Apr

    Bought $MSTX @ .56
    Reply (1)
    • King Callahan | Send Message 19 May
      : sold @ .7
      MSTX vs. ETF Alternatives
      Company Description
      Mast Therapeutics Inc is a biopharmaceutical company developing novel therapies for serious or life-threatening diseases with significant unmet needs. Its pipeline includes MST-188 development programs in adjunctive thrombolytic therapy.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States